Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

White matter hyperintensities (WMHs) on T<sub>2</sub>-weighted images are radiological signs of cerebral small vessel disease. As their total volume is variably associated with cognition, a new approach that integrates multiple radiological criteria is warranted. Location may matter, as periventricular WMHs have been shown to be associated with cognitive impairments. WMHs that appear as hypointense in T<sub>1</sub>-weighted images (T<sub>1</sub>w) may also indicate the most severe component of WMHs. We developed an automatic method that sub-classifies WMHs into four categories (periventricular/deep and T<sub>1</sub>w-hypointense/nonT<sub>1</sub>w-hypointense) using MRI data from 684 community-dwelling older adults from the Whitehall II study. To test if location and intensity information can impact cognition, we derived two general linear models using either overall or subdivided volumes. Results showed that periventricular T<sub>1</sub>w-hypointense WMHs were significantly associated with poorer performance in the trail making A (p = 0.011), digit symbol (p = 0.028) and digit coding (p = 0.009) tests. We found no association between total WMH volume and cognition. These findings suggest that sub-classifying WMHs according to both location and intensity in T<sub>1</sub>w reveals specific associations with cognitive performance.

Original publication

DOI

10.1016/j.nicl.2021.102616

Type

Journal article

Journal

NeuroImage. Clinical

Publication Date

07/03/2021

Volume

30

Addresses

Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Electronic address: luca.melazzini@unimi.it.